Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
307 |
|
| Actual shortage: | 12 (4%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 288 (94%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
48 (16%) |
|
Overdue reports |
3 (21%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-09-01 | 2022-10-02 | 168499 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2023-01-16 | 2023-05-01 | 181139 |
| LEVOTHYROXINE SODIUM INJECTION | 40MCG | SOLUTION | Resolved | 2022-11-03 | 2023-03-10 | 173469 |
| LEVOTHYROXINE SODIUM INJECTION | 100MCG | SOLUTION | Resolved | 2022-11-03 | 2023-03-02 | 173475 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2022-10-02 | 2023-01-16 | 170878 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-08-03 | 2023-08-31 | 201035 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-10-03 | 2023-11-17 | 205907 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0